Effects of 3'-angeloyloxy-4'-acetoxy-3',4'-dihydroseselin on cardiohemodynamics in anesthetized dogs. 1994

T H Chang, and H Adachi, and T Okuyama, and N Mori, and I Saito, and K Y Zhang, and X D Sun, and J M Li
Department of Pharmacology, China Medical University, Shenyang.

Cardiohemodynamic effects of 3'-angeloyloxy-4'-acetoxy-3',4'-dihydroseselin (Pd-Ia) isolated from the Chinese medicinal plant Peucedanum praeruptorum Dunn were compared with those of diltiazem (Dil) in anesthetized open-chest dogs. Pd-Ia 3 mg.kg-1 increased coronary blood flow from 25 +/- 11 to 58 +/- 16 ml.min-1 (n = 7, P < 0.01) and decreased mean aortic pressure (MAP) from 13 +/- 2 to 8 +/- 1 kPa (P < 0.01), rate pressure product (RPP) from 1.9 +/- 0.5 to 1.3 +/- 0.3 MPa.bpm (P < 0.05), +dp/dtmax from 246 +/- 56 to 160 +/- 36 kPa.s-1 (P < 0.01) and systemic vascular resistance from 19 +/- 4 to 12 +/- 7 Pa.ml-1.min-1 (P < 0.05), together with an increase in HR. Dil showed effects similar to those of Pd-Ia except for a marked decrease in HR. The effects of Pd-Ia on MAP and RPP were approximately one-tenth as potent as those of Dil. The results demonstrated that Pd-Ia was a Ca2+ channel blocker.

UI MeSH Term Description Entries
D008297 Male Males
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D003374 Coumarins Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. 1,2-Benzopyrone Derivatives,1,2-Benzopyrones,Coumarin Derivative,Coumarine,1,2-Benzo-Pyrones,Benzopyran-2-ones,Coumarin Derivatives,Coumarines,1,2 Benzo Pyrones,1,2 Benzopyrone Derivatives,1,2 Benzopyrones,Benzopyran 2 ones,Derivative, Coumarin,Derivatives, 1,2-Benzopyrone,Derivatives, Coumarin
D004110 Diltiazem A benzothiazepine derivative with vasodilating action due to its antagonism of the actions of CALCIUM ion on membrane functions. Aldizem,CRD-401,Cardil,Cardizem,Dilacor,Dilacor XR,Dilren,Diltiazem Hydrochloride,Diltiazem Malate,Dilzem,Tiazac,CRD 401,CRD401
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004365 Drugs, Chinese Herbal Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesized compounds manufactured in China. Chinese Herbal Drugs,Plant Extracts, Chinese,Chinese Drugs, Plant,Chinese Plant Extracts,Extracts, Chinese Plant,Herbal Drugs, Chinese
D005260 Female Females

Related Publications

T H Chang, and H Adachi, and T Okuyama, and N Mori, and I Saito, and K Y Zhang, and X D Sun, and J M Li
April 2006, Biological & pharmaceutical bulletin,
T H Chang, and H Adachi, and T Okuyama, and N Mori, and I Saito, and K Y Zhang, and X D Sun, and J M Li
November 1988, Arzneimittel-Forschung,
T H Chang, and H Adachi, and T Okuyama, and N Mori, and I Saito, and K Y Zhang, and X D Sun, and J M Li
October 1990, Japanese journal of pharmacology,
T H Chang, and H Adachi, and T Okuyama, and N Mori, and I Saito, and K Y Zhang, and X D Sun, and J M Li
January 1991, European journal of pharmacology,
T H Chang, and H Adachi, and T Okuyama, and N Mori, and I Saito, and K Y Zhang, and X D Sun, and J M Li
December 1965, Arzneimittel-Forschung,
T H Chang, and H Adachi, and T Okuyama, and N Mori, and I Saito, and K Y Zhang, and X D Sun, and J M Li
January 2016, Chinese medicine,
T H Chang, and H Adachi, and T Okuyama, and N Mori, and I Saito, and K Y Zhang, and X D Sun, and J M Li
January 1975, European journal of pharmacology,
T H Chang, and H Adachi, and T Okuyama, and N Mori, and I Saito, and K Y Zhang, and X D Sun, and J M Li
May 2003, American journal of veterinary research,
T H Chang, and H Adachi, and T Okuyama, and N Mori, and I Saito, and K Y Zhang, and X D Sun, and J M Li
January 1993, Acta physiologica Hungarica,
T H Chang, and H Adachi, and T Okuyama, and N Mori, and I Saito, and K Y Zhang, and X D Sun, and J M Li
May 1988, Circulatory shock,
Copied contents to your clipboard!